CCCharlotte CharpentierPharmD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Seminal HIV-1 RNA and drug concentrations in DTG+3TC dual therapy (ANRS167 Lamidol)- Charlotte CharpentierView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019First results after 52 weeks of informal PrEP use in a cohort of MSM in Southern Spain - Manuel Reiriz RojasView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019European surveillance of HIV drug resistance to NRTI, NNRTI and INSTI in newly diagnosed individuals using next-generation sequencing - Carole Seguin-DevauxView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019New approaches to STI management- Gary Whitlock, MDView Slideset
RPRoger ParedesMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Genetic Barrier – Clinical Cases- Roger Paredes, MD, PhDView Slideset
CFPCarlo Federico PernoMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019How does the reservoir influence the clinician's decisions- Carlo Federico Perno, MD, PhDView Slideset
RGRavindra GuptaMA, MPH, BMBCh, PhD, FRCP, FRCPath, FMedSciSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Andrea De Luca Lecture: The top 10 important observations of the last year affecting clinical management- Ravindra Gupta, MD, PhDView Slideset
DRDanvic RosadiñoDIHSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Community Perspective of Demedicalization of PrEP- Danvic RosadiñoView Slideset
HSHeather-Marie SchmidtBMedSc (Hon), MPH, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Provider’s Perspective of PrEP Demedicalization- Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDView Slideset
CHChien-Ching HungMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Epidemic of Acute HCV: What Have We Learned?- Chien-Ching Hung, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2019Hepatitis B Therapy Pipeline: How Far Are We From Cure- Peter Revill, PhDView Slideset
